effect of shirish(Rain Tree)kwath(Decoction) on amavata(Arthritis)

Clinical efficacy of shirish (Albizia lebbeck (L.)Benth.)kwath as vishaghna dravya in amavata - C.E.S.K.V.D.A

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013465

Enrollment

Registered

2018-04-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient Diagnosed with Amavatha Health Condition 2: M069- Rheumatoid arthritis, unspecified Health Condition 3: M069- Rheumatoid arthritis, unspecified Health Condition 4: M069- Rheumatoid arthritis, unspecified Health Condition 5: M069- Rheumatoid arthritis, unspecified Health Condition 6: M069- Rheumatoid arthritis, unspecified

Interventions

Intervention1: Shirish (Albizia lebbeck (L.)Benth.)ghan vati: Crude bark of albizia lebeck (L.)Benth. Was taken and grinded to coarse powder and decoction was prepared as per classical method given in

Eligibility

Inclusion criteria

Inclusion criteria: patients having classical features of amavata

Exclusion criteria

Exclusion criteria: Acute/Severe Rheumatoid Arthritis, gout, osteoarthritis etc Having severe crippling deformity. Patients with other systemic diseases like Cardiac disease, Tuberculosis, Diabetes mellitus, Hypertension. Patients with extremely reduced joint space. Pregnant women & lactating mother.

Design outcomes

Primary

Measure	Time frame
The work is yet to be startedTimepoint: The work is yet to be started	—

Secondary

Measure	Time frame
The work is yet to be startedTimepoint: The work is yet to be started	—

Countries

India

Contacts

Public ContactDr Ramesh Chandra Tiwari

Rishikul Campus Haridwar, Uttrakhand Ayurveda University

ketanmangwal78@gmail.com8988295001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026